Nose-to-Brain Co-delivery of Temozolomide and Ganoderma lucidum Spore Oil in a Microemulsion for Enhanced Glioblastoma Therapy

Temozolomide (TMZ)-based chemotherapy for glioblastoma (GBM) is severely limited by the blood–brain barrier (BBB) and the highly immunosuppressive tumor microenvironment (TME). Ganoderma lucidum spore oil (GSO) has TME-remodeling capacity, but its efficient delivery to the brain remains challenging. Here, we developed a TMZ and GSO coloaded microemulsion (TMZ&GSO-MEs) optimized for intranasal nose-to-brain delivery. Using an “active ingredient-as-excipient” design, GSO partially replaced the conventional oil phase, resulting in a uniform nanoscale formulation (∼35 nm), high encapsulation efficiency (92.6%), and sustained release. TMZ&GSO-MEs significantly enhanced cellular uptake of both TMZ and GSO and exhibited superior antiproliferative activity in GL261 cells compared to free TMZ. In an orthotopic Luc-GL261 glioma model, intranasal administration of TMZ&GSO-MEs markedly suppressed tumor growth (inhibition rate 66.5%) and extended survival (25% of mice alive at day 60). Mechanistically, GSO reprogrammed the TME by increasing M1-type tumor-associated macrophages, CD8+ T cells, and activated dendritic cells, while decreasing M2-type macrophages and TGF-β1 and shifting serum cytokines toward a Th1-dominant profile. Notably, the formulation showed a favorable safety profile with no significant body weight loss or hepatorenal toxicity. Collectively, this nose-to-brain microemulsion integrates enhanced intracranial delivery, chemo-immunotherapeutic synergy, and reduced toxicity, offering a promising strategy for GBM therapy.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-19
DOI
https://doi.org/10.1021/acsomega.6c07252
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nose-to-Brain Co-delivery of Temozolomide and Ganoderma lucidum Spore Oil in a Microemulsion for Enhanced Glioblastoma Therapy

Xiaoyuan Guo, Xingxing Jin, Hongmei Liu, Zhibo Zhang
ACS Omega
Advanced Drug Delivery Systems
article

Nose-to-Brain Co-delivery of Temozolomide and Ganoderma lucidum Spore Oil in a Microemulsion for Enhanced Glioblastoma Therapy

Xiaoyuan Guo, Xingxing Jin, Hongmei Liu, Zhibo Zhang
article en

Abstract

Temozolomide (TMZ)-based chemotherapy for glioblastoma (GBM) is severely limited by the blood–brain barrier (BBB) and the highly immunosuppressive tumor microenvironment (TME). Ganoderma lucidum spore oil (GSO) has TME-remodeling capacity, but its efficient delivery to the brain remains challenging. Here, we developed a TMZ and GSO coloaded microemulsion (TMZ&GSO-MEs) optimized for intranasal nose-to-brain delivery. Using an “active ingredient-as-excipient” design, GSO partially replaced the conventional oil phase, resulting in a uniform nanoscale formulation (∼35 nm), high encapsulation efficiency (92.6%), and sustained release. TMZ&GSO-MEs significantly enhanced cellular uptake of both TMZ and GSO and exhibited superior antiproliferative activity in GL261 cells compared to free TMZ. In an orthotopic Luc-GL261 glioma model, intranasal administration of TMZ&GSO-MEs markedly suppressed tumor growth (inhibition rate 66.5%) and extended survival (25% of mice alive at day 60). Mechanistically, GSO reprogrammed the TME by increasing M1-type tumor-associated macrophages, CD8+ T cells, and activated dendritic cells, while decreasing M2-type macrophages and TGF-β1 and shifting serum cytokines toward a Th1-dominant profile. Notably, the formulation showed a favorable safety profile with no significant body weight loss or hepatorenal toxicity. Collectively, this nose-to-brain microemulsion integrates enhanced intracranial delivery, chemo-immunotherapeutic synergy, and reduced toxicity, offering a promising strategy for GBM therapy.

ACS Omega
Southeast University (CN)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon